Home
About ALect2
Symptoms & Diagnosis
Patient Resources
Patient Stories
Other Foundations
Additional Resources
For Physicians
Symptoms and Risk Factors
Diagnosis & Treatment
Current Research
Contact Us
References
Figure adapted from Alect2 amyloidosis: primum non nocere (first, do no harm).
14
Diagnosis
Congo red staining of a renal biopsy
Antibody or proteomic methods, such as mass spectrometry to type amyloidosis.
14
Prognosis
1 out of every 3 patients developed end-stage renal disease.
17
Median renal survival was 62 months.
17
ALect2 is often misdiagnosed as an amyloidosis derived from immunoglobulin light chain (AL).
14
Creatinine levels have been suggested as a prognostic tool (See below).
17
Treatment
Currently, there is no effective treatment.
14
Home
About ALect2
Symptoms & Diagnosis
Patient Resources
Patient Stories
Other Foundations
Additional Resources
For Physicians
Symptoms and Risk Factors
Diagnosis & Treatment
Current Research
Contact Us
References